Congress should consider changing the FDA Safety and Innovation Act, which has not prevented shortages of injected drugs, John R. Graham writes. The FDA should be made into a "certifier of certifiers," allowing eligible third parties to certify new drug manufacturing facilities, he writes. Shifting Medicare reimbursement for some injected drugs from Part B to Part D can help as well.

Full Story:

Related Summaries